Log in to save to my catalogue

Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study

Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c61603f586d34df6b7a34a1f86705733

Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study

About this item

Full title

Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study

Publisher

England: BioMed Central Ltd

Journal title

BMC neurology, 2024-03, Vol.24 (1), p.96-96, Article 96

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The Limb Girdle Muscular Dystrophies (LGMDs) are characterized by progressive weakness of the shoulder and hip girdle muscles as a result of over 30 different genetic mutations. This study is designed to develop clinical outcome assessments across the group of disorders.
The primary goal of this study is to evaluate the utility of a set of outco...

Alternative Titles

Full title

Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c61603f586d34df6b7a34a1f86705733

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c61603f586d34df6b7a34a1f86705733

Other Identifiers

ISSN

1471-2377

E-ISSN

1471-2377

DOI

10.1186/s12883-024-03588-1

How to access this item